Comparison Kalaris Therapeutics (KLRS) with Competitors
Kalaris Therapeutics (KLRS) industry is Biotechnology.
Free Cash Flow Yield
KLRS-38.54%
Industry-1.75%
Upside-36.79%
P/E
KLRS-2.24
Industry-20.52
Upside+1827.70%
P/B
KLRS1.59
Industry5.15
Upside-69.13%